Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Roberts

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Nature Genetics|March 23, 2021
A first-generation pediatric cancer dependency mapNeekesh V Dharia, Guillaume Kugener, Lillian M Guenther, et al.
Nature Genetics|September 19, 2018
Mutational processes shape the landscape of TP53 mutations in human cancerAndrew O Giacomelli, Xiaoping Yang, Robert E Lintner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2020
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor HomoharringtonineThomas P Howard, Elaine M Oberlick, Matthew G Rees, et al.
Nature Genetics|September 12, 2020
Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumorsAnton G Henssen, Richard Koche, Jiali Zhuang, et al.
Nature Genetics|September 28, 2017
Erratum: PGBD5 promotes site-specific oncogenic mutations in human tumorsAnton G Henssen, Richard Koche, Jiali Zhuang, et al.
Nature|March 28, 2024
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNFSandi Radko-Juettner, Hong Yue, Jacquelyn A Myers, et al.
Nature|April 29, 2024
Author Correction: Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNFSandi Radko-Juettner, Hong Yue, Jacquelyn A Myers, et al.
Nature Genetics|May 16, 2017
PGBD5 promotes site-specific oncogenic mutations in human tumorsAnton G Henssen, Richard Koche, Jiali Zhuang, et al.
Cancer Research|February 14, 2019
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid TumorsThomas P Howard, Taylor E Arnoff, Melinda R Song, et al.
Cell Reports|August 29, 2019
Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid TumorsElaine M Oberlick, Matthew G Rees, Brinton Seashore-Ludlow, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Nature Genetics|March 23, 2021
A first-generation pediatric cancer dependency mapNeekesh V Dharia, Guillaume Kugener, Lillian M Guenther, et al.
Nature Genetics|September 19, 2018
Mutational processes shape the landscape of TP53 mutations in human cancerAndrew O Giacomelli, Xiaoping Yang, Robert E Lintner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2020
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor HomoharringtonineThomas P Howard, Elaine M Oberlick, Matthew G Rees, et al.
Nature Genetics|September 12, 2020
Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumorsAnton G Henssen, Richard Koche, Jiali Zhuang, et al.
Nature Genetics|September 28, 2017
Erratum: PGBD5 promotes site-specific oncogenic mutations in human tumorsAnton G Henssen, Richard Koche, Jiali Zhuang, et al.
Nature|March 28, 2024
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNFSandi Radko-Juettner, Hong Yue, Jacquelyn A Myers, et al.
Nature|April 29, 2024
Author Correction: Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNFSandi Radko-Juettner, Hong Yue, Jacquelyn A Myers, et al.
Nature Genetics|May 16, 2017
PGBD5 promotes site-specific oncogenic mutations in human tumorsAnton G Henssen, Richard Koche, Jiali Zhuang, et al.
Cancer Research|February 14, 2019
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid TumorsThomas P Howard, Taylor E Arnoff, Melinda R Song, et al.
Cell Reports|August 29, 2019
Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid TumorsElaine M Oberlick, Matthew G Rees, Brinton Seashore-Ludlow, et al.
Pageof 16